← Back to TCM Global · All articles

From Health Food to Functional Cosmetics: Navigating China's Ingredient Rules

2026-10-23

One Ingredient, Many Regulatory Doors

A single ginsenoside can be a health food ingredient, a cosmetic active, a drug candidate — each category with its own rules, claims and timelines. Giant Biogene's ten-year journey touched all of them. Understanding this regulatory map is essential for anyone sourcing or formulating ginseng products.

The Three Main Doors in China

1. Health Food (Blue Hat)

• Path: registration or filing with safety and function evidence
• Claims: bounded function claims (e.g., fatigue support) under approved templates
• Timeline: long; the 2016 Shengan health food preceded the cosmetic work by a decade

2. Cosmetic New Ingredient

• Path: registration with identity, purity, safety data — the route CK completed in June 2026
• Claims: cosmetic claims only (soothing, antioxidant positioning) — no therapeutic language
• Value: a registered active is a defensible, marketable asset

3. Drug

• Path: the longest — full pharmaceutical development. Ginsenoside Rg3's injection approval shows it's possible but rare

The Strategic Sequence That Worked

Giant Biogene's order — health food first, then skincare, then ingredient registration, then new brands — wasn't accidental:

• Early categories build revenue and data while science matures
• Registration milestones compound into assets
• Consumer brands monetize the accumulated credibility

Compliance Rules That Apply Everywhere

1. No disease claims in food or cosmetics — the line between 'supports' and 'treats' is the most common violation
2. Identity documentation: registered ingredients carry filing numbers buyers should verify
3. Label accuracy: active content per serving must match specs

For International Buyers

China's registration system increasingly produces exportable documentation: a CK registration dossier supports safety discussions in other markets. When sourcing China-origin ginseng actives, ask for the regulatory paper trail — it is the cheapest due diligence available.

The Takeaway

Regulatory strategy is product strategy. The companies winning in ginseng actives are those that treat registrations as compounding assets — each one opening a door the next product walks through.

Explore more Eastern wellness wisdom at TCM Global.